On Friday, Eton Pharmaceuticals Inc (NASDAQ: ETON) was -11.70% drop from the session before settling in for the closing price of $19.14. A 52-week range for ETON has been $8.43 – $23.00.
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.22%. When this article was written, the company’s average yearly earnings per share was at 360.00%. With a float of $22.84 million, this company’s outstanding shares have now reached $26.82 million.
Eton Pharmaceuticals Inc (ETON) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Eton Pharmaceuticals Inc stocks. The insider ownership of Eton Pharmaceuticals Inc is 14.84%, while institutional ownership is 62.43%. The most recent insider transaction that took place on Aug 19 ’25, was worth 631,565. In this transaction Chief Financial Officer of this company sold 39,082 shares at a rate of $16.16, taking the stock ownership to the 205,299 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Chief Financial Officer sold 2,631 for $16.02, making the entire transaction worth $42,149. This insider now owns 204,753 shares in total.
Eton Pharmaceuticals Inc (ETON) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.03 earnings per share (EPS) during the time that was less than consensus figure (set at -0) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.2 per share during the current fiscal year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Trading Performance Indicators
You can see what Eton Pharmaceuticals Inc (ETON) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.45. Likewise, its price to free cash flow for the trailing twelve months is 21.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 1.20 in one year’s time.
Technical Analysis of Eton Pharmaceuticals Inc (ETON)
Looking closely at Eton Pharmaceuticals Inc (NASDAQ: ETON), its last 5-days average volume was 0.46 million, which is a jump from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 49.87%.
During the past 100 days, Eton Pharmaceuticals Inc’s (ETON) raw stochastic average was set at 38.48%, which indicates a significant increase from 15.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.06 in the past 14 days, which was higher than the 0.91 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.81, while its 200-day Moving Average is $16.43. However, in the short run, Eton Pharmaceuticals Inc’s stock first resistance to watch stands at $18.73. Second resistance stands at $20.57. The third major resistance level sits at $21.76. If the price goes on to break the first support level at $15.70, it is likely to go to the next support level at $14.51. Should the price break the second support level, the third support level stands at $12.67.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Key Stats
There are 26,818K outstanding shares of the company, which has a market capitalization of 453.22 million. As of now, sales total 39,010 K while income totals -3,820 K. Its latest quarter income was 18,930 K while its last quarter net income were -2,590 K.
